ZBTB9 is a zinc finger and BTB domain-containing transcription factor that functions as a context-dependent regulator of nuclear hormone signaling and cell proliferation. In mature adipocytes, ZBTB9 acts as a positive regulator of peroxisome proliferator-activated receptor-γ (PPARγ) signaling 1. Conversely, in preadipocytes, ZBTB9 functions as a negative regulator of adipogenesis by suppressing PPARγ expression through inhibition of the RB-E2F1 signaling pathway 12. This cell-state-dependent mechanism explains ZBTB9's association with metabolic traits identified in genome-wide association studies, including body mass index, type 2 diabetes risk, and HbA1c levels 1. Beyond metabolic regulation, ZBTB9 is significantly overexpressed in hepatocellular carcinoma, where it promotes tumor progression and poor prognosis by activating cell cycle, DNA repair, and MYC/KRAS-associated signaling pathways while inducing immune dysregulation 3. ZBTB9 knockdown substantially inhibits cancer cell proliferation and migration 3. Additionally, genetic variants in the ZBTB9-BAK1 region are associated with increased chr6 obstructive pulmonary disease risk 4 and platelet count variation in Hispanic populations 5. These findings establish ZBTB9 as a multifunctional transcriptional regulator with significant roles in metabolic homeostasis, malignant transformation, and hematologic function.